UK markets close in 2 hours 11 minutes
  • FTSE 100

    7,422.35
    +119.61 (+1.64%)
     
  • FTSE 250

    20,019.58
    +330.56 (+1.68%)
     
  • AIM

    959.29
    +12.12 (+1.28%)
     
  • GBP/EUR

    1.1819
    +0.0037 (+0.31%)
     
  • GBP/USD

    1.2491
    +0.0017 (+0.13%)
     
  • BTC-GBP

    24,227.26
    +358.26 (+1.50%)
     
  • CMC Crypto 200

    674.86
    +22.63 (+3.47%)
     
  • S&P 500

    3,900.79
    -22.89 (-0.58%)
     
  • DOW

    31,253.13
    -236.94 (-0.75%)
     
  • CRUDE OIL

    111.71
    -0.50 (-0.45%)
     
  • GOLD FUTURES

    1,840.60
    -0.60 (-0.03%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    14,120.65
    +238.35 (+1.72%)
     
  • CAC 40

    6,351.73
    +79.02 (+1.26%)
     

Composition of the Nomination Committee of Orion Corporation

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Orion Oyj
Orion Oyj

ORION CORPORATION
STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE
29 APRIL 2022 at 10.50 EEST

Composition of the Nomination Committee of Orion Corporation

The Board of Directors of Orion Corporation has appointed the following persons to the Nomination Committee of the company:

  • Annika Ekman

  • Petteri Karttunen

  • Timo Maasilta

  • Hilpi Rautelin

  • Mikael Silvennoinen

  • Heikki Westerlund

Heikki Westerlund was appointed as Chairman of the Committee.

The Committee prepares and presents a recommendation to the Board of Directors for the proposal to the Annual General Meeting concerning the composition of the Board.

The essentials of the working order of the Nomination Committee and a description of the appointment process of its members are provided at https://www.orion.fi/en/Orion-group/corporate-governance/board-of-directors/board-committees/, a page in the Corporate Governance section of the Orion Group internet website.

Orion Corporation

Timo Lappalainen

President and CEO

Olli Huotari

SVP, Corporate Functions


Contact person:
Timo Lappalainen, President and CEO
tel. +358 10 426 3692

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are currently neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting